Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Henderson Michael Thomas
Relationship:   Officer, Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   1,763,698    

Indirect Shares

  0      
Direct Value   $68,917,014    

Indirect Value

  $0      
Total Shares   1,763,698      
Total Value   $68,917,014      


Bridgebio Pharma, Inc.
 $7,639,518 Apogee Therapeutics, Inc.
 $61,277,495 Bridgebio Pharma, Inc.
 $7,639,518 Apogee Therapeutics, Inc.
 $61,277,495
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bridgebio Pharma, Inc. BBIO Chief Business Officer 2020-12-01 274,211 2019-07-01 0    Premium*  
            Apogee Therapeutics, Inc. APGE Officer, Director 2023-07-13 1,489,487 0    Premium*  
* Premium Members only  

Records found :    36         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-09-18 4 AS $40.00 $400,000 D/D (10,000) 267,751 0 %
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-09-18 4 OE $0.16 $2,212 D/D 10,000 277,751 0 -
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-10-01 4 OE $0.28 $7,994 D/D 10,000 277,751 0 -
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-10-01 4 AS $38.29 $388,342 D/D (10,000) 267,751 0 %
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-11-02 4 AS $38.33 $383,558 D/D (10,000) 267,751 0 %
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-11-02 4 OE $1.05 $10,500 D/D 10,000 277,751 0 -
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-11-16 4 D $44.33 $281,628 D/D (6,353) 274,211 0 -
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-11-16 4 OE $0.00 $10,500 D/D 22,813 280,564 0 -
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-11-16 4 AS $45.00 $450,000 D/D (10,000) 267,751 0 %
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-12-01 4 AS $51.12 $515,204 D/D (10,000) 274,211 0 %
BBIO Bridgebio Pharma, Inc. Chief Business Officer   •       –      –    2020-12-01 4 OE $1.05 $10,500 D/D 10,000 284,211 0 -

  36  Records found
  1   2     
  Page 2 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed